Search This Blog

Wednesday, November 12, 2025

CorMedix Ups FY 2025 Guidance

 ‒ Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million ‒

‒ Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million ‒

‒ FY 2025 Pro Forma Net Revenue Guidance Raised to a Range of $390 to $410 million ‒

‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒

The management team of CorMedix will host a conference call and webcast today, November 12, 2025, at 8:30AM Eastern Time, to discuss recent corporate developments and financial results. Call details and dial-in information are as follows:

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.